Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3608)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 24, 2023 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ma SX, Li L, Cai H, Guo TK, Zhang LS. Therapeutic challenge for immunotherapy targeting cold colorectal cancer: A narrative review. World J Clin Oncol 2023; 14(2): 81-88 [PMID: 36908678 DOI: 10.5306/wjco.v14.i2.81] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v14/i2/81.htm |
| Number | Citing Articles |
| 1 |
Abdullah Elsayed, Louis Plüss, Larissa Nideroest, Giulia Rotta, Marina Thoma, Nathan Zangger, Frederik Peissert, Stefanie K. Pfister, Christian Pellegrino, Sheila Dakhel Plaza, Roberto De Luca, Markus G. Manz, Annette Oxenius, Emanuele Puca, Cornelia Halin, Dario Neri. Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer. Molecular Cancer Therapeutics 2024; 23(7): 1010 doi: 10.1158/1535-7163.MCT-23-0766
|
| 2 |
Ke Xin Lin, Alexandra C. Istl, Douglas Quan, Anton Skaro, Ephraim Tang, Xiufen Zheng. PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies. Cancer Immunology, Immunotherapy 2023; 72(12): 3875 doi: 10.1007/s00262-023-03520-5
|
| 3 |
Dalia Martinez-Marin, Rebecca A. Helmer, Gurvinder Kaur, Rachel L. Washburn, Raul Martinez-Zaguilan, Souad R. Sennone, Jannette M. Dufour, Beverly S. Chilton, Zhiming Li. Helicase-like transcription factor (HLTF)-deleted CDX/TME model of colorectal cancer increased transcription of oxidative phosphorylation genes and diverted glycolysis to boost S-glutathionylation in lymphatic intravascular metastatic niches. PLOS ONE 2023; 18(9): e0291023 doi: 10.1371/journal.pone.0291023
|
| 4 |
Karla K Frietze, Kamala Anumukonda, Laura Padula, Natasha Strbo, Neil Goldstein. Directed protein engineering identifies a human TIM-4 blocking antibody that enhances anti-tumor response to checkpoint inhibition in murine colon carcinoma. Antibody Therapeutics 2024; doi: 10.1093/abt/tbae026
|